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A 61-year-old man presented to his private physician with a I -month complaint of increasing weakness. His hemoglobin level was 5.0 g/dL. The patient was referred to UTMDACC for therapy.
The patient was found to have RAEBT (2/4/88) with 17% marrow blasts and the presence of Auer rods. The peripheral blood contained 3% blasts at this time. The patient was begun on fludarabine phosphate, which was stopped I month later (March 1988) due to toxicity.
The patient was changed to cytosine arabinoside and daunomycin.
On May 12, 1988 the patient developed a peripheral blast count of 56%, while the aspirate contained I 5% marrow blasts. On June 30, 1988 the aspirate contained 36% blasts, and the patient was begun on doxorubicin hydrochloric acid, cytosine arabinoside, and prednisone.
The patient did not achieve a complete remission and continues to have elevated blast counts in the marrow aspirates. The patient was a 33-year-old woman with a 1-month history of increasing fatigue. Upon examination by her outside physician, she was found to be anemic and thrombocytopenic. Blasts with Auer rods were present in the peripheral smear. The hemoglobin value was 4.4 g/dL, the platelet count was 12,000flzL, and the white count was 20,000/ iL.
She had 17% blasts in the BM with rare Auer rods and was diagnosed as having RAEBT 
